AKT1 Q79K
|
Melanoma
|
AKT1 Q79K
|
Melanoma
|
vemurafenib Resistant: C3 – Early Trials
|
vemurafenib Resistant: C3 – Early Trials
|
AKT1 Q79K
|
Melanoma
|
AKT1 Q79K
|
Melanoma
|
vemurafenib + MK-2206 Sensitive: D – Preclinical
|
vemurafenib + MK-2206 Sensitive: D – Preclinical
|